The effect of COVID-19 on the thromboembolic outcomes in atrial fibrillation patients in the long run

References

• Al-Samkari H, Karp Leaf RS, Dzik WH, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136(4):489–500. doi: 10.1182/blood.2020006520.
   PubMed Web of Science ®Google Scholar
• Paris S, Inciardi RM, Lombardi CM, et al. Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study. Europace. 2021;23(10):1603–1611. doi: 10.1093/europace/euab146.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Munir MB, Stavrakis S, et al. The impact of atrial fibrillation on outcomes in patients hospitalized with COVID-19. Eur J Intern Med. 2023;111:127–129. doi: 10.1016/j.ejim.2023.01.017.
   PubMed Web of Science ®Google Scholar
• Omar T, Karakayalı M, Perincek G. Assessment of COVID-19 deaths from cardiological perspective. Acta Cardiol. 2022;77(3):231–238. doi: 10.1080/00015385.2021.1903704.
   PubMed Web of Science ®Google Scholar
• Romiti GF, Corica B, Lip GYH, et al. Prevalence and impact of atrial fibrillation in hospitalized patients with COVID-19: a systematic review and meta-analysis. J Clin Med. 2021;10(11):2490. doi: 10.3390/jcm10112490.
   PubMed Web of Science ®Google Scholar
• Søgaard M, Skjøth F, Nielsen PB, et al. Thromboembolic risk in patients with pneumonia and New-Onset atrial fibrillation not receiving anticoagulation therapy. JAMA Netw Open. 2022;5(5):e2213945. doi: 10.1001/jamanetworkopen.2022.13945.
   PubMed Web of Science ®Google Scholar
• Tralhão A, Póvoa P. Cardiovascular events after community-acquired pneumonia: a global perspective with systematic review and meta-analysis of observational studies. J Clin Med. 2020;9(2):414. doi: 10.3390/jcm9020414.
   PubMed Web of Science ®Google Scholar
• Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690. doi: 10.1001/jamaneurol.2020.1127.
   PubMed Web of Science ®Google Scholar
• Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268–2270. doi: 10.1056/NEJMc2008597.
   PubMed Web of Science ®Google Scholar
• Merkler AE, Parikh NS, Mir S, et al. Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol. 2020;77(11):1–7. doi: 10.1001/jamaneurol.2020.2730.
   PubMed Web of Science ®Google Scholar
• Benussi A, Pilotto A, Premi E, et al. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy. Neurology. 2020;95(7):e910–e920. doi: 10.1212/WNL.0000000000009848.
   PubMed Web of Science ®Google Scholar
• Fara MG, Stein LK, Skliut M, et al. Macrothrombosis and stroke in patients with mild covid-19 infection. J Thromb Haemost. 2020;18(8):2031–2033. doi: 10.1111/jth.14938.
   PubMed Web of Science ®Google Scholar
• Yaghi S, Ishida K, Torres J, et al. SARS-CoV-2 and stroke in a New York healthcare system. Stroke. 2020;51(7):2002–2011. doi: 10.1161/STROKEAHA.120.030335.
   PubMed Web of Science ®Google Scholar
• Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22(8):983–988. doi: 10.1161/01.str.22.8.983.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. JAMA. 1994;271(11):840–844. doi: 10.1001/jama.1994.03510350050036.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance. Geneva: World Health Organization; 2020.
   Google Scholar
• Kusumawardhani NY, Putra ICS, Kamarullah W, et al. Cardiovascular disease in post-acute COVID-19 syndrome: a comprehensive review of pathophysiology and diagnosis approach. Rev Cardiovasc Med. 2023;24(1):28. doi: 10.31083/j.rcm2401028.
   Web of Science ®Google Scholar
• Ashton R, Ansdell P, Hume E, et al. COVID-19 and the long-term cardio-respiratory and metabolic health complications. Rev Cardiovasc Med. 2022;23(2):53. doi: 10.31083/j.rcm2302053.
   PubMed Web of Science ®Google Scholar
• Hanff TC, Mohareb AM, Giri J, et al. Thrombosis in COVID-19. Am J Hematol. 2020;95(12):1578–1589. doi: 10.1002/ajh.25982.
   PubMed Web of Science ®Google Scholar
• Pepera G, Tribali M-S, Batalik L, et al. Epidemiology, risk factors and prognosis of cardiovascular disease in the coronavirus disease 2019 (COVID-19) pandemic era: a systematic review. Rev Cardiovasc Med. 2022;23(1):28. doi: 10.31083/j.rcm2301028.
   PubMed Web of Science ®Google Scholar
• Hazarapetyan LG, Zelveian PH, Grigoryan SV. Features of atrial fibrillation pathogenesis and prognosis in chronic obstructive pulmonary patients during the COVID-19 pandemic. Rev Cardiovasc Med. 2023;24(2):51. doi: 10.31083/j.rcm2402051.
   Web of Science ®Google Scholar
• Boriani G, Guerra F, De Ponti R, et al. Five waves of COVID-19 pandemic in Italy: results of a national survey evaluating the impact on activities related to arrhythmias, pacing, and electrophysiology promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing). Intern Emerg Med. 2023;18(1):137–149. doi: 10.1007/s11739-022-03140-4.
   PubMed Web of Science ®Google Scholar
• Pavasini R, Fabbri G, Di Ienno L, et al. Left atrial pressure in patients with respiratory failure due to SARS-CoV-2 infection and supraventricular arrythmias. J Cardiovasc Med. 2022;23(6):414–416. doi: 10.2459/JCM.0000000000001291.
   Google Scholar
• Denegri A, Pezzuto G, D'Arienzo M, et al. Clinical and electrocardiographic characteristics at admission of COVID-19/SARS-CoV2 pneumonia infection. Intern Emerg Med. 2021;16(6):1451–1456. doi: 10.1007/s11739-020-02578-8.
   PubMed Web of Science ®Google Scholar
• Yang H, Liang X, Xu J, et al. Meta-analysis of atrial fibrillation in patients with COVID-19. Am J Cardiol. 2021;144:152–156. doi: 10.1016/j.amjcard.2021.01.010.
   PubMed Web of Science ®Google Scholar
• Russo V, Silverio A, Scudiero F, et al. Pre-admission atrial fibrillation in COVID-19 patients: prevalence and clinical impact. Eur J Intern Med. 2021;88:133–135. doi: 10.1016/j.ejim.2021.03.017.
   PubMed Web of Science ®Google Scholar
• O'Shea CJ, Middeldorp ME, Thomas G, et al. Atrial fibrillation burden during the coronavirus disease 2019 pandemic. Europace. 2021;23(9):1493–1501. doi: 10.1093/europace/euab099.
   PubMed Web of Science ®Google Scholar
• Lip GYH, Genaidy A, Tran G, et al. Incident atrial fibrillation and its risk prediction in patients developing COVID-19: a machine learning based algorithm approach. Eur J Intern Med. 2021;91:53–58. doi: 10.1016/j.ejim.2021.04.023.
   PubMed Web of Science ®Google Scholar
• REMAP-CAP Investigators, ACTIV-4a Investigators, ATTACC Investigators, et al. Therapeutic anticoagulation with heparin in critically ill patients with covid-19. N Engl J Med. 2021;385:777–789. doi: 10.1056/NEJMoa2103417.
   PubMed Web of Science ®Google Scholar
• Ye X, Huang C, Yan VKC, et al. Sex-based differences in risk of ischemic stroke or systemic embolism after BNT162b2 or CoronaVac COVID-19 vaccination in patients with atrial fibrillation: a self-controlled case series and nested case-control study. Eur Heart J Cardiovasc Pharmacother. 2023;9(5):403–412. doi: 10.1093/ehjcvp/pvad015.
   PubMed Web of Science ®Google Scholar
• Louis DW, Kennedy KF, Saad M, et al. Preadmission oral anticoagulation for atrial fibrillation/flutter and death or thrombotic events during COVID-19 admission. Am J Cardiol. 2022;181:38–44. doi: 10.1016/j.amjcard.2022.07.006.
   PubMed Web of Science ®Google Scholar
• Romiti GF, Corica B, Pipitone E, et al. Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients. Eur Heart J. 2021;42(35):3541–3554. doi: 10.1093/eurheartj/ehab453.
   PubMed Web of Science ®Google Scholar
• Proietti M, Laroche C, Drozd M, et al. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: a report from the EURObservational research programme pilot survey on atrial fibrillation (EORP-AF) general registry. Am Heart J. 2016;181:83–91. doi: 10.1016/j.ahj.2016.08.011.
   PubMed Web of Science ®Google Scholar
• Hu W-S, Lin C-L. CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study. Europace. 2018;20(4):575–581. doi: 10.1093/europace/eux065.
   PubMed Web of Science ®Google Scholar